Task force on vaccines and viral diseasesFunded under: TF-VACCINES C
The Task Force on Vaccine and Viral Diseases (TFV-V) aims at improving European and global welfare by taking full account of the opportunities arising from scientific advances and new technologies. This information pack describes the activities of TFV-V. Vaccination is widely recognized as one of the most efficient tools of public health policy showing evident cost-benefit advantages for all target populations involved. The TFV-V activities were conceived sequentially including a first stage vaccine research and development for human health with an emphasis towards viral diseases. A broad consultation targeted to potential partners from industry, public institutions and agencies and universities and research centres, has contributed to the identification of the needs and priorities for research both in the fields of vaccines and viral diseases. The Task Force has held bilateral meetings with Industry and regulatory authorities that set the ground for cooperative projects. Meetings on specific topics served to refine and focus the needs and priorities of research in major need for support at a European level. Finally, a Round Table discussion gathering eminent representatives from governments, industry and academia held in December 1995 allowed a general consensus on what initiatives should be promoted in the fields of vaccines and viral diseases. As a result of all these activities, an first report has been drafted by the commission services.
Bibliographic Reference: Information pack: EN (1996) 37pp.
Availability: Available from the European Commission, Task Force Vaccines and Viral Diseases, DG XII, 200 rue de la Loi, B-1049 Bruxelles (BE), Fax: +32-2-2966608
Record Number: 199730005 / Last updated on: 1997-04-01
Original language: en
Available languages: en